Yeni Tip Koronavirüs (COVID-19) Salgını

Year 2020, , 153 - 162, 30.09.2020

Özlem Şahin Akboğa

https://doi.org/10.38108/ouhcd.715182

Cited By: 1

Abstract

Çin’in Wuhan kentinde tespit edilen, deniz ürünlerinin toptan satış pazarında zoonotik kaynaklı olan yeni tip koronavirüs salgını ve tüm dünyayı etkisi altına alan küresel bir boyuta ulaşmıştır. Hastalığın, insandan insana bulaştırıcılığın yüksek olması nedeni ile tüm dünyada kısa sürede yayılmış ve on dört milyondan fazla kişiyi enfekte etmiştir. Sadece Amerika’da tespit edilen vaka sayısı 4 milyona yaklaşmıştır. Avrupa’nın bazı bölgelerinde COVİD -19 kaynaklı ölüm oranları, salgının çıktığı Hubei şehrindeki ölüm oranlarının 7,5 katını aşmıştır. Türkiye ise, doğrulanmış vaka sayısı ile salgının görüldüğü dünya ülkeleri arasında on beşinci sırada yer almıştır. Her geçen gün vaka ve ölüm sayılarında artışa neden olan bu salgın, Dünya Sağlık Örgütü (DSÖ) tarafından pandemi olarak ilan etmiştir. Covid-19 ile ilişkili klinik belirtiler için bilgiler halen sınırlıdır. Kişisel tedbirlere uyulması, salgının önlenmesinde en etkili yol olarak görülmektedir. Hastalık damlacık ve temas yolu ile bulaşmaktadır. Pandemi sürecinde yapılan çalışmaların sonucunda COVID-19’un doğal seyrine ilişkin bilgiler her geçen gün netlik kazanmaktadır.

Keywords

Yeni tip Koronavirüs, 2019-nCoV, pandemi, önlem ve kontol

Supporting Institution

Yozgat Bozok Üniversitesi Sağlık Bilimler Fakültesi

Project Number

0

Thanks

Ülkemizde bu salgın ile mücadele eden başta sağlık çalışanları olmak üzere diğer tüm kurumlara ve “evde kal” çağrısına uyan Türk halkına teşekkürlerimi sunarım.

New Type Coronavirus (COVID-19) Outbreak

Abstract

In Wuhan, China, new type of coronavirus outbreak from zoonotic origin in the wholesale market of seafood has reached a global dimension affecting the whole world. It has infected more than fourteen million people spread all over the world in a short time due to high disease-to-person transmissibility. The number of cases detected only in America has approached 4 million. In some parts of Europe, death rates from COVID -19 have exceeded 7.5 times the mortality rates in the city of Hubei, where the outbreak occurred. Meanwhile, Turkey has taken place fifth among ten countries in the world where the epidemic with the number of confirmed cases seen. This epidemic, which has increased the number of cases and deaths day by day, has been declared as a pandemic by the World Health Organization (WHO). Information for clinical symptoms associated with Covid-19 is still limited. When personal precautions are followed, it is seen as the most effective way to prevent epidemic. The disease is transmitted by droplet and contact. As a result of the work done in the pandemic process, Information on the natural course of COVID-19, is getting clearer day by day.

Keywords

New type Coronavirus, 2019-nCoV, prevention and control, pandemic

Project Number

0

References

• Abbott S, Hellewell J, Munday JC, Funk S. (2020). The transmissibility of novel coronavirus in the early stages of the 2019–20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis. Wellcome Open Research, 5, 17.
• Ahmad T, Khan M, Khan FM, Hui J. (2020). Are we ready for the new fatal Coronavirus: scenario of Pakistan?. Human Vacciness Immunotherapeutics, 1–3. doi:10.1080/21645515.2020.1724000.
• Ai J, W, Zhang Y, Zhang HC, Xu T, Zhang WH. (2020). Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned. Emerging Microbes & Infections, 9(1), 597-600.
• Ak Ö. (2020). Soğuk algınlığından ölümcül salgına! Küresel kâbus. TUBİTAK, 1-16. Erişim Tarihi: 27.03.2020, Erişim Adresi: https://tubitak.gov.tr/sites/default/files/18842/bilim_ve_teknik_coronavirus_hakkinda.pdf.
• Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E ve ark. (2020). Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine, 1-34.
• Ali I, Alharbi OM. (2020). COVID-19: Disease, management, treatment, and social impact. Science of the Total Environment, 138861.
• Armitage R, Nellums LB. (2020). COVID-19 and the consequences of isolating the elderly. The Lancet Public Health, 5(5), e256.
• Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L ve ark. (2020). Presumed asymptomatic carrier transmission of COVID-19. JAMA, 323, 323(14), 1406-1407.
• Caccialanza R, Laviano A, Lobascio F, Montagna E, Bruno R, Ludovisi S ve ark. (2020). Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition,74,110835, doi:10.1016/j.nut.2020.110835.
• Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, Li F. (2020). Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. Journal of Sport and Health Science, 9 (2): 103-4.
• Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. (2009). The spike protein of SARS– CoV–a target for vaccine and therapeutic development. Nature Reviews Microbiology, 7:226–36.
• Jernigan DB. (2020). Update: Public health response to the Coronavirus disease 2019 Outbreak-United States. Morbidity and Mortality Weekly Report 69,8, 216-219.
• Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP ve ark. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research, 7, 4, 1-23.
• Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW ve ark. (2020). Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health, 8,e488-496.
• Centers for Disease Control and Prevention (CDCa). Coronavirus disease 2019 (COVID-19): situation summary. Erişim Tarihi: 26.03.2020, Erişim Adresi: https://www.cdc.gov/coronavirus/2019-ncov/summary.html.
• Centers for Disease Control and Prevention (CDCb). Erişim tarihi: 26.03.2020, Erişim Adresi: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
• Centers for Disease Control and Prevention (CDCc). Erişim tarihi: 27.03.2020, Erişim Adresi: https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html.
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y ve ark. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497-506.
• Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly CA, Riley S ve ark. (2020). Report 3: transmissibility of 2019-nCoV. Imperial College London. Erişim tarihi: 28.03.2020, Erişim Adresi: https://www.imperial.ac.uk/media/imperialcollege/ medicine/sph/ide/gida-fellowships/Imperial-2019-nCoVtransmissibility. Karcıoğlu Ö. (2020). What is Coronaviruses, and how can we protect ourselves?. Phoneix Medical Journal, 2,66-71.
• Lai CC, Shihb TP, Koc WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55,10924. https://doi.org/10.1016/j.ijantimicag.2020.105924.
• Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y ve ark. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 146,1,110-118.
• Liu J, Liu S. (2020). The management of coronavirus disease 2019 (COVID‐19). Journal of Medical Virology, 92, 9,doi:10.1002/jmv.25965.
• Liu S, Yang L, Zhang C, Xiang Y, Liu Z, Hu S ve ark. (2020). Online mental health services in China during the COVID-19 outbreak. The Lancet Psychiatry, 7(4), e17–e18.
• National Institutes of Health, NIH. Erişim tarihi: 26.03.2020, Erişim Adresi: https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces.
• Özlü A, Öztaş D. (2020). Yeni corona pandemisi (COVID-19) ile mücadelede geçmişten ders çıkartmak. Ankara Medical Journal, (2), 468-48.
• Parodi SM, Liu VX. (2020). From containment to mitigation of COVID-19 in the US. JAMA, e1-e2.
• Russell CD, Millar JE, Baillie JK. (2020). Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet, 395:473–5.
• Singhal T. (2020). A review of Coronavirus Disease-2019 (COVID-19). Indian Journal of Pediatrics, 87(4), 281-286. Sistem Bilimi ve Mühendisliği Merkezi. Erişim tarihi: 19.07.2020, Erişim Adresi: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.
• Sohrabia C, Alsafib Z, O'Neilla N, Khanb M, Kerwanc A, Al-Jabir A ve ark. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76,71-6. https://doi.org/10.1016/j.ijsu.2020.02.034.
• Tauseef A, Jin H. (2020). One health approach and Coronavirus Disease 2019. Human Vaccınes & Immunotherapeutics. Erişim Tarihi: 26.03.2020, Erişim Adresi: https://doi.org/10.1080/21645515.2020.1732168 T.C Halk Sağlığı Genel Müdürlüğü, 2019-nCoV Hastalığı Sağlık Çalışanları Rehberi Mart, 2020. Erişim tarihi: 27.03.2020. https://covid19.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf.
• T.C. Sağlık Bakanlığı Günlük Koronavirüs Tablosu. Erişim Tarihi: 19.07.2020, Erişim Adresi: https://covid19.saglik.gov.tr/. World Health Organization (WHO). Erişim tarihi: 19.07.2020, Erişim Adresi: https://covid19.who.int/
• Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S ve ark. (2020). Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Journal of Zhejiang University (medical science), 49(1), 147-157.
• Yang LL, Yang T. (2020). Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Diseases and Translational Medicine,6,2,79-86.
• Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. (2020). The epidemiology, diagnosis and treatment of COVID-19. International Journal of Antimicrobial Agents, 55,5,105955.
• Zhao JP, Hu Y, Du RH, Chen ZS, Jin Y, Zhou M ve ark. (2020). Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases, 43(3), 183-184.
• Zhao HM, Xie YX, Wang C. (2020). Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chinese medical journal, 133(13), 1595-1602.
• Zhang L, Liu Y. (2020). Potential interventions for novel coronavirus in China: a systemic review. Journal of Medical Virology, 92(5), 479-490. https://doi.org/10. 1002/jmv.25707.
• Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W ve ark. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-273